Understanding how Down syndrome affects Alzheimer's disease

Toward a neuroscientific understanding of the interaction between Down syndrome and Alzheimer's disease pathology

NIH-funded research Stanford University · NIH-11101250

This study is looking at how Down syndrome and Alzheimer's disease are connected, using special brain scans to find out how the brains of people with Down syndrome change as they get older, so we can help catch Alzheimer's early and support those at risk.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionStanford University NIH-funded
Lab location1 site (Stanford, United States)
Project IDNIH-11101250 on NIH RePORTER

What this research studies

This research investigates the relationship between Down syndrome and Alzheimer's disease by using advanced neuroimaging techniques and biomarkers. It aims to identify brain changes and neuropsychological patterns in individuals with Down syndrome as they age, particularly focusing on the onset of Alzheimer's disease. By analyzing brain connectivity and microstructure through MRI and other methods, the study seeks to uncover critical information that could lead to early interventions before significant cognitive decline occurs. This research is particularly relevant for individuals with Down syndrome, who have a high risk of developing Alzheimer's disease as they age.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with Down syndrome, particularly those over the age of 40, who may be at risk for Alzheimer's disease.

Not a fit: Patients without Down syndrome or those who are not at risk for Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to earlier diagnosis and targeted interventions for individuals with Down syndrome at risk of Alzheimer's disease.

How similar studies have performed: Previous research has shown promising results in understanding neurodegenerative diseases in populations with genetic predispositions, suggesting that this approach could yield valuable insights.

Where this research is happening

Stanford, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.